Journal Article Research Support, N.I.H., Extramural Epublish 22 citations
PubMed: 29300776 DOI: 10.1371/journal.pone.0190347
Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana.
PLoS One 13(1):e0190347
Authors: Amma Benneh-Akwasi Kuma, Amma Twumwa Owusu-Ansah, Mary Akua Ampomah, Fredericka Sey, Edeghonghon Olayemi, Mehdi Nouraie, Solomon Fiifi Ofori-Acquah
Affiliations
- Department of Hematology, College of Health Sciences, University of Ghana, Accra, Ghana.
- Division of Hematology Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
- Center for Translational and International Hematology, Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
- Ghana Institute of Clinical Genetics, Korle-Bu, Accra, Ghana.
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Heart, Lung and Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Abstract
Individuals with sickle cell disease particularly with the homozygous (SS) genotype historically have relatively low blood pressure. Nonetheless, they develop vasculopathy-associated organ dysfunction and the risk of organ dysfunction increases at blood pressures that are normal in the general population. This phenomenon is termed relative systemic hypertension (RSH) with a systolic blood pressure range of 120-139 mmHg, and diastolic blood pressure range of 70-89 mmHg. The significance of RSH lies in its association with renal insufficiency, pulmonary hypertension, stroke and propensity to progress to systemic hypertension. We conducted a retrospective chart review of 1,000 adults with sickle cell disease at the Ghana Institute of Clinical Genetics, to determine the prevalence of RSH in sickle cell disease in Ghana and associated complications. We found a high prevalence of RSH and hypertension with a relatively low frequency of renal insufficiency. Pulse pressure, a predictor of mortality, was higher in males of all ages. We anticipate that providing an estimate of the burden of RSH will heighten its recognition and clinical management among health care providers.
MeSH
Cells, Hypertension, Blood, Anemia, Sickle Cell, Blood Pressure, Prevalence, Renal Insufficiency
Cited by
- Clinical characteristics and risk factors of relative systemic hypertension and hypertension among sickle cell patients in Cameroon. Front Med (Lausanne), 2022
- Myocardial Performance Index Among Patients of Sickle Cell Disorder in Rural Teaching Hospital: A Case-Control Study. Cureus, 2021
- Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysis. Blood Adv, 2022
- The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol, 2022
- Impact of relative systemic hypertension on the heart in sickle cell anaemia. Indian Heart J, 2021
- Prevalence and determinants of medication adherence among patients taking antihypertensive medications in Africa: A systematic review and meta-analysis 2010-2021. Nurs Open, 2023
- Factors associated with blood pressure variation in sickle cell disease patients: a systematic review and meta-analyses. Expert Rev Hematol, 2022
- Factors influencing blood pressure fluctuation in pediatric patients with sickle cell disease in Saudi Arabia: A retrospective single-center cohort study. Saudi Med J, 2023
- Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial. Lancet Haematol, 2024
- How I treat the older adult with sickle cell disease. Blood, 2019